Study of polymorphisms in the interleukin-4 and IL-4 receptor genes in a population of Brazilian patients with multiple sclerosis

Arq Neuropsiquiatr. 2007 Mar;65(1):15-9. doi: 10.1590/s0004-282x2007000100005.

Abstract

This study aimed to investigate in a population of Brazilian patients with multiple sclerosis (MS) single-nucleotide polymorphisms (SNP) in the promoter region of IL4 (*33C-T) and receptor IL4R (*Q551R A-G) genes proposed to interfere with disease progression. No significant differences were observed in either of the SNPs investigated between healthy controls (n=135) and MS patients (n=129). However, the IL4+33 TT genotype was significantly (p=0.039) higher in African descendants MS (AF-MS= 9.09%) than in Caucasian MS (CA-MS= 1.35%). It was also observed a significant (p=0.016) increase for the IL4R* Q551R CC genotype in AF-MS compared to those of Caucasian ethnicity (AF-MS= 21.62%; CA-MS= 4.35%). These results suggest that IL4+33 and IL4R*Q551 polymorphisms may have a disease-promoting role of TH2 mediators in African MS descendants. Additionally neither IL4 nor IL4R genes are susceptibility factors for Brazilian MS but may be able to modify ethnicity-dependent disease risk and penetrance of susceptibility factors.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Black People
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Interleukin-4 / genetics*
  • Male
  • Middle Aged
  • Multiple Sclerosis / genetics*
  • Polymorphism, Single Nucleotide*
  • Receptors, Interleukin-4 / genetics*
  • White People

Substances

  • Receptors, Interleukin-4
  • Interleukin-4